MONCTON, NEW BRUNSWICK--(Marketwired - Oct. 16, 2015) - OrganiGram Holdings Inc. (TSX VENTURE:OGI)(OTCQX:OGRMF) (the "Company") announces the granting of 574,165 stock options at an exercise price of $0.30 per share to officers and employees of the Company pursuant to the Company's stock option plan.
Additionally, the Company advises that 175,000 stock options were issued to consultants of the Company with an exercise price of $0.40 per share and 150,000 stock options were issued to consultants of the Company with an exercise price of $0.30 per share.
Upon the granting of the Options described above, OrganiGram will have 2,706,013 Options outstanding. OrganiGram's stock option plan currently limits the issuance of Options to no more than 10% of the outstanding Common Shares.
The option grants are subject to TSX Venture Exchange approval.
About OrganiGram Holdings Inc.
OrganiGram Holdings Inc. is a TSX Venture Exchange listed company whose wholly owned subsidiary, OrganiGram Inc., is a licensed producer of medical marijuana in Canada. OrganiGram is focused on producing the highest quality, condition specific medical marijuana for patients in Canada. OrganiGram's facility is located in Moncton, New Brunswick and the Company is regulated by the Marihuana for Medical Purposes Regulations.
Please visit www.organigram.ca for more information.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contact Information:
Brett Allan
Director of Investor Relations
(416) 907-4148
brett@organigram.ca
www.organigram.ca